Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC).Robert Wesolowski, Bhuvaneswari Ramaswamy, Susan M. Geyer et al.|Journal of Clinical Oncology|2014Cited by 16